Progressive multifocal leukoencephalopathy, a rare entity with a fatal outcome. Case presentation

Authors

DOI:

https://doi.org/10.53903/01212095.300

Keywords:

Leukoencephalopathy progressive multifocal, JC virus, Acquired immunodeficiency syndrome, Neuroimaging

Abstract

Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection caused by the reactivation of the John Cunningham neurotrophic virus, which develops an infectious process in cases of severe immunosuppression. Magnetic resonance imaging is the preferred imaging method for diagnosis. Imaging characteristics include the identification of asymmetric and generalized areas in the white matter, with high signal intensity in T2-weighted sequences, little mass effect, diffusion restriction and little enhancement after administration of contrast medium. We present the case of a 31-year-old patient with a clinical course of neurocognitive deterioration, with magnetic resonance findings compatible with PML. The main characteristics and key points for imaging diagnosis will be described.

Downloads

Download data is not yet available.

References

Moens U, Krumbholz A, Ehlers B, Zell R, Johne R, Calvignac-Spencer S, et al. Biology, evolution, and medical importance of polyomaviruses: An update. Infect Genet Evol. 2017;54:18-38. https://doi.org/10.1016/j.meegid.2017.06.011

Monaco MC, Atwood WJ, Gravell M, Tornatore CS, Major EO. JC virus infection ofhematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol. 1996;70(10):7004-12. https://doi.org/10.1128/JVI.70.10.7004-7012.1996

Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol. 2021;17(1):37-51. https://doi.org/10.1038/s41582-020-00427-y

Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik U, Sejvar J, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013;80(15):1430-8. https://doi.org/10.1212/WNL.0b013e31828c2fa1

Garrels K, Kucharczyk W, Wortzman G, Shandling M. Progressive multifocal leukoencephalopathy: clinical and MR response to treatment. AJNR Am J Neuroradiol. 1996;17(3):597-600. PMID: 8881262; PMCID: PMC8337997

Bezuidenhout AF, Andronikou S, Ackermann C, Du Plessis AM, Basson D, Bhadelia R. A. “Barbell Sign”: A diagnostic imaging finding in progressive multifocal leukoencephalopathy. J Comp Assist Tomog. 2018;42(4):527-30 https://doi.org/10.1097/RCT.0000000000000719

Adra N, Goodheart AE, Rapalino O, Caruso P, Mukerji SS, González R, et al. MRI shrimp sign in cerebellar progressive multifocal leukoencephalopathy: description and validation of a novel observation. Am J Neuroradiol. 2021;42(6)1073-9. https://doi.org/10.3174/ajnr.A7145

Yousry TA, Pelletier D, Cadavid D, Gass A, Richert N, Raude E, et al. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol. 2012;72:779-87. https://doi.org/10.1002/ana.23676

Wattjes MP, Vennegoor A, Steenwijk MD, de Vos M, Killestein J, van Ooste B, et al. MRI pattern in asymptomatic natalizumab-associated PML. J Neurol Neurosurg Psychiatr. 2015;86:793-8. https://doi.org/10.1136/jnnp-2014-308630

Bergui M, Bradac GB, Oguz KK, Boghi A, Geda C, Gatti G, et al. Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology. 2004;46(1):22-5. https://doi.org/10.1007/s00234-003-1115-9

Cosottini M, Tavarelli C, Del Bono L, Doria G, Giannelli M, De Cori S, et al. Diffusionweighted imaging in patients with progressive multifocal leukoencephalopathy. Eur Radiol. 2008;18(5):1024-30. https://doi.org/10.1007/s00330-007-0845-1

Küker K, Mader I, Nägele T, Uhl M, Adolph C, Klose U, et al. Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control. Eur J Neurol. 2006;13(8):819-26. https://doi.org/10.1111/j.1468-1331.2006.01362.x

Mader I, Herrlinger U, Klose U, Schmidt F, Küker W. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology. 2003;45(10):717-21. https://doi.org/10.1007/s00234-003-0966-4

Iranzo A, Moreno A, Pujol J, Martí-Fábregas J, Domingo P, Molet J, et al. Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS. J Neurol, Neurosurg Psychiatry. 1999;66(4):520-3. https://doi.org/10.1136/jnnp.66.4.520

Williamson EML, Berger JR. Diagnosis and treatment of progressive multifocal leukoencephalopathy associated with multiple sclerosis therapies. Neurotherapeutics. 2017;14(4):961-73. https://doi.org/10.1007/s13311-017-0570-7

Cinque P, Koralnik IJ, Gerevini S, Miro JM, Price RW. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis. 2009;9(10):625-36. https://doi.org/10.1016/S1473-3099(09)70226-9

Fournier A, Martin-Blondel G, Lechapt-Zalcman E, Dina J, Kazemi A, Verdon R, et al. Immune reconstitution inflammatory syndrome unmasking or worsening aids-related progressive multifocal leukoencephalopathy: a literature review. Front Immunol. 2017;8:577. https://doi.org/10.3389/fimmu.2017.00577

Published

2024-03-30

How to Cite

(1)
Manrique Salas, J. P.; Quintero Díaz, L. M.; Navarro Estrada, B. M.; Lemus Velázquez, M.; Tapia Garzón, Y. K. Progressive Multifocal Leukoencephalopathy, a Rare Entity With a Fatal Outcome. Case Presentation. Rev. colomb. radiol. 2024, 35, 6126-6129.